デフォルト表紙
市場調査レポート
商品コード
1609556

自己注射器市場の市場規模、シェア、動向分析:製品別、ユーザビリティ別、用途別、地域別、セグメント予測、2025年~2030年

Self-injection Devices Market Size, Share & Trends Analysis By Product (Auto Injectors, Pen Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders), By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
自己注射器市場の市場規模、シェア、動向分析:製品別、ユーザビリティ別、用途別、地域別、セグメント予測、2025年~2030年
出版日: 2024年11月06日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

自己注射器市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の自己注射器市場規模は2025年から2030年にかけて10.31%のCAGRを記録し、2030年までに405億米ドルに達すると予測されています。

患者数の増加、慢性疾患の有病率の上昇、高度なドラッグデリバリーシステムの高い採用率は、自己注射デバイスの需要を急増させると推定される要因です。

医療従事者や企業が自己注射器などの自己注射デバイスを導入する主な要因は、針刺し傷害の防止です。医療従事者の針刺し損傷を避けるため、米国、欧州、その他の市場では安全器具の使用が義務付けられています。いくつかの自動注射器は、医療従事者に針刺し防止という付加的な特典を提供しています。米国では、年間約69,000件の傷害を防止できると予想されています。数多くの自動注射器には、傷害のリスクを排除または軽減する一体型および受動型の安全機能が備わっています。

新しいドラッグデリバリーシステム(NDDDS)の分野における革新は、自己投与薬に対する需要の高まりにつながっています。プレフィルドシリンジ、ペン型注射器、自動注射器、無針注射器などの新しい注射デリバリー機器の発明により、患者にとって薬剤の自己投与がより簡単で便利になった。生物学的製剤の大部分は注射によって投与されるが、これには針刺し損傷の恐れがあります。この問題を最小化するため、製薬会社は自己注射針不要の注射器や患者にやさしい薬と器具の組み合わせ製品を開発しています。

COVID-19の大流行は、投与環境に対する期待や認識を変化させ、自己投与薬への嗜好を高める一因となった。これが当たり前になるにつれ、いくつかのメーカーはドラッグデリバリーの設計において患者の体験を重要な要素とする傾向にあります。COVID-19ワクチンは、注射器に対する需要を増大させるだろうし、パンデミックは、自己使用型デバイスや接続型デバイスの利点も示しています。パンデミック後は、デバイスの今後の技術革新が高まる可能性があり、製薬メーカーは、アプリ、電話、パソコンなど他のデジタル資産と組み合わせて自己注射デバイスを使用するために徐々に協力するようになると思われます。最終的には、患者が自分のケアをはるかにコントロールできるようになると思われます。

自己注射器市場レポートハイライト

  • 市場は製品別に自動注射器、ペン型注射器、ウェアラブル注射器、無針注射器に分類されます。無針注射器分野は、その高い有効性と世界の普及率により、2024年には市場の約28.32%を占め、最大のシェアを占める。
  • 使用性に基づいて、市場は再使用型と使い捨て型に区分されます。使い捨てセグメントは2024年に約62.64%の市場シェアを占める。
  • 市場は用途別に、がん、疼痛管理、自己免疫疾患、ホルモン疾患、その他に区分されます。がんは主要セグメントのひとつで、2021年の市場シェアは約26.82%でした。
  • 北米の自己注射器市場は世界市場全体を支配し、2024年の売上高シェアの42.44%を占めました。北米市場は、セルフメディケーションに対する患者の嗜好の高まり、がん患者の増加、ホルモン疾患の増加など、いくつかの要因によって牽引されています。
  • アジア太平洋の自己注射器市場は、主にインド、中国、日本などの主要国における医療インフラの急速な進歩、慢性疾患の治療への投資の増加によって、大幅な成長を遂げています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 自己注射器市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • 自己注射器市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 自己注射器市場:製品推定・動向分析

  • セグメントダッシュボード
  • 自己注射器市場:製品変動分析
  • 自己注射器市場:製品別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • オートインジェクター
  • ペン型注射器
  • ウェアラブルインジェクター
  • 無針注射器

第5章 自己注射器市場:ユーザビリティの推定・動向分析

  • セグメントダッシュボード
  • 自己注射器市場:ユーザビリティ変動分析
  • ユーザビリティ展望による自己注射器市場
  • 2018年から2030年までの市場規模と予測および動向分析
  • 使い捨て
  • 再利用可能

第6章 自己注射器市場:用途の推定・動向分析

  • セグメントダッシュボード
  • 自己注射器市場:用途変動分析
  • 自己注射器市場の用途別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • がん
  • 自己免疫疾患
  • 疼痛管理
  • その他

第7章 自己注射器市場:地域別推定・動向分析

  • 地域ダッシュボード
  • 地域別自己注射器市場変動分析
  • 自己注射器市場:技術と最終用途別の地域別推定・動向分析
  • 2018年から2030年までの市場規模と予測および動向分析
  • 北米
    • 米国
    • カナダ
    • メキシコ
    • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 市場参入企業の分類
  • 主要企業プロファイル
    • YPSOMED
    • BD
    • Gerresheimer AG
    • Antares Pharma, Inc.
    • Haselmeier AG
    • NuGen Medical Devices
    • Owen Mumford Ltd.
    • SHL Medical AG.
    • Pfizer, Inc.
    • Amgen Inc.
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 4. Global self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 5. Global self-injection devices market, by application, 2018 - 2030 (USD million)
  • Table 6. North America self-injection devices market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 8. North America self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 9. North America self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 10. U.S. self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 11. U.S. self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 12. U.S. self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 13. Canada self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 14. Canada self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 15. Canada self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 16. Mexico self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 17. Mexico self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 18. Mexico self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 19. Europe self-injection devices market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 21. Europe self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 22. Europe self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 23. UK self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 24. UK self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 25. UK self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 26. Germany self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 27. Germany self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 28. Germany self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 29. France self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 30. France self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 31. France self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 32. Italy self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 33. Italy self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 34. Italy self-injection devices market, by application e, 2018 - 2030 (USD Million)
  • Table 35. Spain self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 36. Spain self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 37. Spain self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 38. Norway self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 39. Norway self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 40. Norway self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 41. Sweden self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 42. Sweden self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 43. Sweden self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 44. Denmark self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 45. Denmark self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 46. Denmark self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific self-injection devices market, by country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 51. Japan self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 52. Japan self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 53. Japan self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 54. China self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 55. China self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 56. China self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 57. India self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 58. India self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 59. India self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 60. Australia self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 61. Australia self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 62. Australia self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 63. South Korea self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 64. South Korea self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 65. South Korea self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 66. Thailand self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 67. Thailand self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 68. Thailand self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 69. Latin America self-injection devices market, by country, 2018 - 2030 (USD Million)
  • Table 70. Latin America self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 71. Latin America self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 72. Latin America self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 73. Brazil self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 74. Brazil self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 75. Brazil self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 76. Argentina self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 77. Argentina self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 78. Argentina self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 79. Middle East & Africa self-injection devices market, by country, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 83. South Africa self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 84. South Africa self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 85. South Africa self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 89. UAE self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 90. UAE self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 91. UAE self-injection devices market, by application, 2018 - 2030 (USD Million)
  • Table 92. Kuwait self-injection devices market, by product, 2018 - 2030 (USD Million)
  • Table 93. Kuwait self-injection devices market, by usability, 2018 - 2030 (USD Million)
  • Table 94. Kuwait self-injection devices market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Information Procurement
  • Fig 2. Primary Research Pattern
  • Fig 3. Market Research Approaches
  • Fig 4. Value Chain-Based Sizing & Forecasting
  • Fig 5. Market Formulation & Validation
  • Fig 6. Self-injection devices market segmentation
  • Fig 7. Market driver analysis (Current & future impact)
  • Fig 8. Market restraint analysis (Current & future impact)
  • Fig 9. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig 10. Porter's Five Forces Analysis
  • Fig 11. Self-injection devices market, product outlook key takeaways (USD Million)
  • Fig 12. Self-injection devices market product movement analysis , 2023 & 2030 (USD Million)
  • Fig 13. Autoinjectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 14. Pen injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 15. Wearable injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 16. Needle-free injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 17. Self-injection devices market, usability outlook key takeaways (USD Million)
  • Fig 18. Self-injection devices market usability movement analysis , 2023 & 2030 (USD Million)
  • Fig 19. Disposable market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 20. Reusable market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 21. Self-injection devices market, application outlook key takeaways (USD Million)
  • Fig 22. Self-injection devices market application movement analysis , 2023 & 2030 (USD Million)
  • Fig 23. Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 24. Autoimmune disorders market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 25. Hormonal disorders market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 26. Pain management market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 27. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 28. Self-injection devices market: Regional key takeaways (USD Million)
  • Fig 29. Self-injection devices market regional outlook, 2023 & 2030, USD Million
  • Fig 30. North America self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 31. U.S. self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 32. Canada self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 33. Mexico self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 34. Europe self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 35. UK self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 36. Germany self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 37. France self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 38. Spain self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 39. Italy self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 40. Sweden self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 41. Norway self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 42. Denmark self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 43. Asia Pacific self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 44. China self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 45. Japan self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 46. India self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 47. South Korea self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 48. Australia self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 49. Thailand self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 50. Latin America self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 51. Brazil self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 52. Argentina self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 53. Middle East and Africa self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 54. South Africa self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 55. Saudi Arabia self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 56. UAE self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 57. Kuwait self-injection devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 58. List of key emerging company's/technology disruptors/innovators
目次
Product Code: GVR-4-68039-919-4

Self-injection Devices Market Growth & Trends:

The global self-injection devices market size is expected to reach USD 40.50 billion by 2030, registering a CAGR of 10.31% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing patient volume and rising prevalence of chronic diseases along with the high adoption of advanced drug delivery systems are factors estimated to surge the demand for self-injection devices.

Prevention of needlestick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as autoinjectors. To avoid needlestick injuries to healthcare workers, the U.S., Europe, and other markets mandate the use of safety devices. Several auto-injectors provide the additional benefit of needlestick protection to healthcare professionals. It is expected that in the U.S. about 69,000 injuries can be prevented annually. Numerous auto-injectors have integral and passive safety features that eliminate or reduce the risk of injury.

Innovation in the field of New Drug Delivery Systems (NDDDS) has led to the rising demand for self-administered medications. The invention of novel injectable delivery devices such as pre-filled syringes, pen injectors, autoinjectors, and needle-free injectors has made the self-administration of drugs easier and more convenient for patients. The majority of biological drugs are delivered using injections, which include the threat of needlestick injuries. To minimize this issue, pharmaceutical firms are developing self-administered needle-free injectors and patient-friendly medication-device combination products.

The COVID-19 pandemic has altered expectations and perceptions of delivery settings and contributed to a rise in preference for self-administration medication. As this becomes the norm, several manufacturers are inclined to make the patient experience the vital component of drug delivery design. Significantly, the COVID-19 vaccines will increase the demand for injectable devices and the pandemic has also shown the benefit of self-use devices as well as connected devices. Post-pandemic there may be a rise in upcoming innovation in devices and pharma manufacturers will progressively collaborate to use self-injection devices in combination with other digital assets such as apps, phones, and personal computers. Eventually, this will bring the patient into far greater control of their care.

Self-injection Devices Market Report Highlights:

  • The market is classified by product into auto-injectors, pen injectors, wearable injectors, and needle-free injectors. The needle-free injector segment held the largest share, accounting for around 28.32% of the market in 2024, due to its high effectiveness and adoption rates worldwide.
  • Based on usability, the market is segmented into reusable and disposable. The disposable segment held around 62.64% market share in 2024.
  • The market is segmented by application into cancer, pain management, autoimmune disorders, hormonal disorders, and others. Cancer is among the leading segments, holding around 26.82% market share in 2021.
  • North America self-injection devices market dominated the overall global market and accounted for 42.44% of revenue share in 2024. The North American market is driven by several factors, including increased preference of the patients toward self-medication, increasing cancer cases, and rising cases of hormonal diseases.
  • The Asia Pacific self-injection devices market is experiencing substantial growth, primarily driven by rapidly advancing healthcare infrastructure in key countries such as India, China, and Japan, alongside increasing investments in treating chronic disorders.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Self-injection Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing preference for self-administration
      • 3.2.1.2. Rising prevalence of hormonal disorders
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of Infection and Complications
  • 3.3. Self-injection Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Self-injection Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Self-injection Devices Market: Product Movement Analysis
  • 4.3. Self-injection Devices Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Autoinjectors
    • 4.5.1. Autoinjectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Pen injectors
    • 4.6.1. Pen injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Wearable injectors
    • 4.7.1. Wearable injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Needle-free injectors
    • 4.8.1. Needle-free injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Self-injection Devices Market: Usability Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Self-injection Devices Market: Usability Movement Analysis
  • 5.3. Self-injection Devices Market by Usability Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Disposable
    • 5.5.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Reusable
    • 5.6.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Self-injection Devices Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Self-injection Devices Market: Application Movement Analysis
  • 6.3. Self-injection Devices Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Cancer
    • 6.5.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Autoimmune disorders
    • 6.6.1. Autoimmune disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Pain management
    • 6.7.1. Pain management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Self-injection Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Self-injection Devices Market Movement Analysis
  • 7.3. Self-injection Devices Market: Regional Estimates & Trend Analysis by Technology & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. YPSOMED
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. BD
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Gerresheimer AG
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Antares Pharma, Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Haselmeier AG
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. NuGen Medical Devices
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Owen Mumford Ltd.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. SHL Medical AG.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Pfizer, Inc.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Amgen Inc.
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives